Catalyst Pharmaceuticals, Inc.
CPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $164 | $71 | $83 | $39 |
| Dep. & Amort. | $38 | $33 | $1 | $0 |
| Deferred Tax | -$9 | -$18 | $5 | $9 |
| Stock-Based Comp. | $22 | $14 | $8 | $6 |
| Change in WC | $31 | -$37 | $14 | $5 |
| Other Non-Cash | -$6 | $80 | $5 | $0 |
| Operating Cash Flow | $240 | $144 | $116 | $60 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $10 | $0 |
| Inv. Purchases | $0 | -$13 | -$10 | -$10 |
| Inv. Sales/Matur. | $0 | $0 | $19 | $0 |
| Other Inv. Act. | $0 | -$280 | -$10 | $0 |
| Investing Cash Flow | -$1 | -$294 | $9 | -$11 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $141 | $0 | $0 | $0 |
| Stock Repurch. | -$0 | $0 | -$7 | -$12 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$11 | $9 | $4 |
| Financing Cash Flow | $141 | -$11 | $2 | -$8 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $380 | -$161 | $127 | $41 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $138 | $298 | $171 | $130 |
| End Cash | $518 | $138 | $298 | $171 |
| Free Cash Flow | $239 | $62 | $116 | $59 |